Artrya (ASX:AYA), a medical technology company commercialising its Salix AI-powered cloud platform for near real-time, point-of-care assessment and management of coronary artery disease, has announced that Tanner Health has commenced commercial use of the Salix Coronary Plaque module, generating the first fee-per-scan revenues for the company.
Tanner Health, a foundational US commercial customer, has expanded its use of the Salix Coronary Anatomy platform to include assessments using the Coronary Plaque module, integrating it seamlessly into their workflow.
Under the five-year commercial agreement signed in July, Tanner Health pays a monthly subscription fee for the Salix software and can now generate fee-per-scan revenue, supported by a US Category 1 CPT reimbursement rate of US$950 per assessment.